Evan Loh insider trades: Paratek Pharmaceuticals (PRTK) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Evan reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | PRTK | ↓ Sell | 48,967 | $2.20 | $108K | Direct | Aug 10, 2023 (1d) |
| Dec 21, 2022 | PRTK | ↓ Sell10b5-1 | 23,489 | $1.99 | $47K | Direct | Dec 22, 2022 (1d) |
| Dec 13, 2022 | PRTK | ↓ Sell10b5-1 | 99,750 | $1.97 | $196K | Direct | Dec 14, 2022 (1d) |
| Oct 28, 2022 | PRTK | ↓ Sell10b5-1 | 8,805 | $3.47 | $31K | Direct | Nov 1, 2022 (4d) |
| Aug 9, 2022 | PRTK | ↓ Sell10b5-1 | 44,519 | $2.66 | $118K | Direct | Aug 10, 2022 (1d) |
| Dec 15, 2021 | PRTK | ↓ Sell10b5-1 | 87,076 | $4.32 | $376K | Direct | Dec 15, 2021 (0d) |
| Aug 17, 2021 | PRTK | ↓ Sell10b5-1 | 33,931 | $5.12 | $174K | Direct | Aug 18, 2021 (1d) |
| Jun 4, 2021 | PRTK | ↓ Sell10b5-1 | 36,654 | $9.70 | $356K | Direct | Jun 8, 2021 (4d) |
| Mar 15, 2021 | EIGR | ↓ Sell | 2,000 | $10.14 | $20K | Direct | Mar 15, 2021 (0d) |
| Dec 14, 2020 | PRTK | ↓ Sell10b5-1 | 45,000 | $6.81 | $306K | Direct | Dec 15, 2020 (1d) |
| Nov 13, 2020 | PRTK | ↓ Sell10b5-1 | 20,928 | $5.93 | $124K | Direct | Nov 16, 2020 (3d) |
| May 12, 2020 | PRTK | ↓ Sell | 9,595 | $4.75 | $46K | Direct | May 14, 2020 (2d) |
| Dec 12, 2019 | PRTK | ↓ Sell | 14,514 | $3.10 | $45K | Direct | Dec 16, 2019 (4d) |
| Oct 8, 2019 | PRTK | ↓ Sell10b5-1 | 7,818 | $3.82 | $30K | Direct | Oct 8, 2019 (0d) |
| Oct 3, 2019 | PRTK | ↓ Sell10b5-1 | 16,265 | $3.98 | $65K | Direct | Oct 7, 2019 (4d) |
| Dec 13, 2018 | PRTK | ↓ Sell10b5-1 | 11,525 | $6.50 | $75K | Direct | Dec 14, 2018 (1d) |
| Oct 15, 2018 | PRTK | ↓ Sell10b5-1 | 5,200 | $8.96 | $47K | Direct | Oct 16, 2018 (1d) |
| Oct 3, 2018 | PRTK | ↓ Sell10b5-1 | 8,861 | $9.82 | $87K | Direct | Oct 4, 2018 (1d) |
| Jul 2, 2018 | PRTK | ↓ Sell10b5-1 | 12,000 | $9.97 | $120K | Direct | Jul 5, 2018 (3d) |
| Apr 9, 2018 | PRTK | ↓ Sell10b5-1 | 8,084 | $12.70 | $103K | Direct | Apr 10, 2018 (1d) |
| Feb 5, 2018 | PRTK | ↓ Sell10b5-1 | 3,040 | $14.22 | $43K | Direct | Feb 7, 2018 (2d) |
| Jul 5, 2017 | PRTK | ↓ Sell10b5-1 | 4,351 | $23.58 | $103K | Direct | Jul 6, 2017 (1d) |
| Feb 6, 2017 | PRTK | ↓ Sell10b5-1 | 3,106 | $15.09 | $47K | Direct | Feb 8, 2017 (2d) |
| Dec 11, 2015 | PRTK | ↑ Buy | 2,300 | $16.87 | $39K | Direct | Dec 14, 2015 (3d) |
| Nov 16, 2015 | PRTK | ↑ Buy | 3,700 | $16.16 | $60K | Direct | Nov 18, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Evan Loh's insider trades
Evan Loh is CEO at Paratek Pharmaceuticals (PRTK). Since Nov 16, 2015, Evan has reported 2 open-market purchases worth $99K and 23 sales worth $2.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
19 sales (92% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (31 filings), option exercises (2 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRTK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.